# Buvidal · 160 mg · Roztwór do wstrzykiwań o przedłużonym uwalnianiu · amp.-strzyk. 0,45 1 ml



## Poland

- **URPL** — [pl.dose-10060.org](https://pl.dose-10060.org)

## Codes

- **rpl-pack-id** — `143229`
- **eu-number** — `EU/1/18/1336/009`

## Status

- **read** — 2026-11-15T02:02:49Z

## Holder

- Camurus AB

## Proof

Record pl:presentation:143229 version 1, signed ES256 under dosidal-record-1.9dbf5d53.

## Related records in other markets

- [Buvidal 160 mg](https://dosidal.ai/pack/be/585253-01) — BE — same product (EU central number)
- [BUVIDAL](https://dosidal.ai/pack/cz/0255057) — CZ — same product (EU central number)
- [Buvidal](https://dosidal.ai/pack/eu/EU-1-18-1336-009) — EU — same product (EU central number)
- [BUVIDAL 160 MG ELNYÚJTOTT HATÓANYAGLEADÁSÚ OLDATOS INJEKCIÓ](https://dosidal.ai/pack/hu/210909216) — HU — same product (EU central number)
- [Buvidal 160 mg Prolonged-release solution for injection](https://dosidal.ai/pack/ie/EU-1-18-1336-009) — IE — same product (EU central number)
- [Buvidal 160 mg injekčný roztok s predĺženým uvoľňovaním](https://dosidal.ai/pack/sk/8861D) — SK — same product (EU central number)

A link shows how two records are related. It does not say one product can be used in place of another.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
